MUSTANG BIO, INC. Net Income Loss

Quick Answer

MUSTANG BIO, INC. reported Net Income Loss of -$1.92 million for the year ending 2025.

  • MUSTANG BIO, INC. showed an increase of +87.8% in Net Income Loss from 2024 to 2025.
  • This data is from MUSTANG BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
  • XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2015: -$579.0 thousand | Q3 2015: -$716.0 thousand | Q4 2015: -$911.0 thousand | Q1 2016: -$903.0 thousand | Q2 2016: -$1.13 million | Q3 2016: -$1.87 million | Q4 2016: -$8.75 million | Q1 2017: -$3.22 million | Q2 2017: -$5.53 million | Q3 2017: -$6.94 million | Q4 2017: -$15.60 million | Q1 2018: -$6.28 million | Q2 2018: -$5.09 million | Q3 2018: -$7.52 million | Q4 2018: -$11.77 million | Q1 2019: -$9.61 million | Q2 2019: -$10.40 million | Q3 2019: -$10.17 million | Q4 2019: -$16.21 million | Q1 2020: -$11.86 million | Q2 2020: -$14.60 million | Q3 2020: -$12.95 million | Q1 2021: -$14.96 million | Q2 2021: -$14.36 million | Q3 2021: -$17.01 million | Q1 2022: -$19.80 million | Q2 2022: -$19.10 million | Q3 2022: -$19.00 million | Q1 2023: -$16.69 million | Q2 2023: -$16.24 million | Q3 2023: -$10.06 million | Q1 2024: -$5.19 million | Q2 2024: -$8.20 million | Q3 2024: -$1.41 million | Q1 2025: -$153.0 thousand | Q2 2025: -$762.0 thousand | Q3 2025: -$468.0 thousand.
  • Over the full 11 years of available data (2015 to 2025), MUSTANG BIO, INC.'s Net Income Loss has grown by 15.0%.
  • Historical annual values: Fiscal year 2025: -$1.92 million | Fiscal year 2024: -$15.75 million | Fiscal year 2023: -$51.60 million | Fiscal year 2022: -$77.53 million | Fiscal year 2021: -$66.37 million | Fiscal year 2020: -$60.02 million | Fiscal year 2019: -$46.39 million | Fiscal year 2018: -$30.66 million | Fiscal year 2017: -$31.29 million | Fiscal year 2016: -$12.65 million | Fiscal year 2015: -$2.26 million.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: